Alison Evans, PhD

Senior Research Fellow
Drug Safety Research Unit, United Kingdom

Poster(s):

• (333) Case Series Analysis of Immune-Mediated Neurological Events in Vaccinees following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (338) Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (349) Observed versus Expected Analysis of Adverse Events of Special Interest after AZD1222 (ChAdOx1 nCoV-19) Vaccination: Results from a UK Post-authorisation Active Surveillance Study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST